Zymeworks News

Zymeworks Analyst Ratings

BenzingaJun 18 06:14 ET

Zymeworks Analyst Ratings

BenzingaJun 6 06:18 ET

Stifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)

TipRanksMay 8 22:15 ET

Zymeworks Analyst Ratings

BenzingaMay 7 06:23 ET

Zymeworks Analyst Ratings

BenzingaMay 3 14:06 ET

Buy Rating Affirmed for Zymeworks on Strong Pipeline and Upcoming Catalysts

TipRanksMay 3 06:45 ET

Maintaining Hold on Zymeworks: ZW191's Potential Amidst Competitive and Regulatory Hurdles

TipRanksApr 12 06:30 ET

Analysts' Top Healthcare Picks: Zymeworks (ZYME), 89bio (ETNB)

TipRanksMar 13 10:05 ET

Zymeworks Analyst Ratings

BenzingaMar 12 07:18 ET

Buy Rating Affirmed for Zymeworks Amid Positive HERIZON Study Outlook and Robust Commercial Prospects of Zanidatamab

TipRanksMar 12 05:20 ET

Stifel Nicolaus Keeps Their Buy Rating on Zymeworks (ZYME)

TipRanksMar 11 22:11 ET

Zymeworks Analyst Ratings

BenzingaMar 11 06:42 ET

Hold Rating on Zymeworks Amidst Pipeline Adjustments and Clinical Validation Awaited

TipRanksMar 11 00:55 ET

Hold Rating on Zymeworks Amid Anticipation of Future Clinical Trial Outcomes

TipRanksJan 5 06:28 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Zymeworks (ZYME) and Aclaris Therapeutics (ACRS)

TipRanksNov 13, 2023 06:20 ET

Hold Rating for Zymeworks Amid New Preclinical Candidate, Regained Rights, and Anticipated Pipeline Progress: A Comprehensive Financial Analysis

TipRanksNov 10, 2023 06:30 ET

Zymeworks Analyst Ratings

BenzingaAug 15, 2023 07:13 ET

H.C. Wainwright Sticks to Its Hold Rating for Zymeworks (ZYME)

TipRanksAug 15, 2023 06:36 ET

Zymeworks (ZYME) Receives a Buy From Stifel Nicolaus

TipRanksJun 6, 2023 22:16 ET

Zymeworks (ZYME) Receives a Hold From H.C. Wainwright

TipRanksJun 6, 2023 06:25 ET